PINK:COEP

Coeptis Therapeutics Stock Signals

etoro logo Buy COEP
*Your capital is at risk
$14.64
-1.68 (-10.29%)
At Close: Jun 22, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Coeptis Therapeutics Inc.

General

Signal Type Signal Value Data
Score 0.000 51 days ( -16.01 %
Last Price $14.64 -10.29 %
Performance History
7 Days
$12.76 $14.64
14.78%
30 Days
$16.40 $14.64
-10.73%
12 Mos
$7.56 $14.64
93.65%

10/18

Active Buy Signals

Specific Signals

Short Term
Net score: 75.64
Signal Type Signal Value Importance Data
High / Low Buy Very Low $14.02 - $16.62
Position: 23.85% from low / 76.15% from high · Momentum: 23.37%
Trend - 3 mos 43.41 % High Width: 39.60 %
Pred. range - 3 mos $18.80 - $26.25 Low 28.45 % - 79.32 %
Volume Direction Buy High Volume: 117,365 · Direction: 1.00
Pivot Short Sell Very Low Jun 12, 2026 - 6 days
RSI Short Pivot Signal Sell Very Low Jun 18, 2026 - 2 days
Short MA 3 mos Buy Low Jun 17, 2026 - 3 days
Long MA 3 mos Buy Medium Jun 17, 2026 - 3 days
Short/Long MA 3 mos Sell Medium Jun 12, 2026 - 6 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 57.09
Signal Type Signal Value Importance Data
Trend - 12 mos 20.36 % Very High Width: 96.60 %
Pred. range - 12 mos $12.71 - $25.00 High -13.16 % - 70.74 %
Short MA 12 mos Buy Very High Jun 17, 2026 - 3 days
Long MA 12 mos Sell Very High Jun 12, 2026 - 6 days
Short/Long MA 12 mos Buy Very High Apr 27, 2026 - 39 days
Pivot Long Sell Low Nov 26, 2025 - 141 days
RSI Long Pivot Signal Sell Low Jun 18, 2026 - 2 days
Bollinger Buy Medium Nov 30, -0001 - N/A days
MACD Sell High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT COEPTIS THERAPEUTICS INC.
Coeptis Therapeutics
Coeptis Therapeutics, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a Vy-Gen drug product for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; and CD38-Diagnostic, an in vitro screening tool to provide the abilit...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE